Avai Bio, Inc.
Other OTCTotal Valuation
Avai Bio, Inc. carries a market capitalization of 17.24M, placing it among publicly traded companies globally.
| Market Cap | 17.24M |
| Enterprise Value | N/A |
Share Statistics
Avai Bio, Inc. currently has 153.92M shares outstanding.
| Shares Outstanding | 153.92M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -6.04 |
| P/TBV Ratio | -5.76 |
| P/FCF Ratio | -16.24 |
| P/OCF Ratio | -15.43 |
Financial Position
Avai Bio, Inc. maintains a current ratio of 0.04, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.04 |
| Quick Ratio | 0.04 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -22.89 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -387.16 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Avai Bio, Inc.'s stock has declined approximately -71.74856% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | -71.74856% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.27 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -1.39M, while operating income came in at -1.41M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -1.41M |
| Pretax Income | -1.81M |
| Net Income | -1.81M |
| EBITDA | -1.39M |
| EBIT | -1.41M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Total book value stands at -3.25M, with working capital of -3.86M providing operational flexibility.
| Cash & Cash Equivalents | 83,586.00 |
| Total Debt | N/A |
| Net Debt | 2.20M |
| Equity (Book Value) | -3.25M |
| Book Value Per Share | -0.02 |
| Working Capital | -3.86M |
Cash Flow
Avai Bio, Inc. produced -1.18M in operating cash flow over the past twelve months. After subtracting -58,600.00 in capital expenditures, free cash flow totaled -1.24M - equivalent to -0.01 per share.
| Operating Cash Flow | -1.18M |
| Capital Expenditures | -58,600.00 |
| Free Cash Flow | -1.24M |
| FCF Per Share | -0.01 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -6.70 |
| FCF Yield | -6.16 |
Stock Splits
Avai Bio, Inc.'s most recent stock split took place on June 1, 2020 with a 1:20 split ratio.
| Last Split Date | 6/1/2020 |
| Split Ratio | 1:20 |
Scores
Avai Bio, Inc. posts an Altman Z-Score of -25.95, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -25.95 |